Furthermore, expression of both the glutathione synthesis genes GSH1 and GSH2 was greater in the D-HIS-selected population, consistent with these cells higher production of GSH (Fig
Based on current evidence, several practical recommendations can be outlined
When prescribing semaglutide to patients with autoimmune diseases, clinicians should implement a structured approach to patient selection, education, and monitoring
The observed reduction in AUD risk is particularly noteworthy given the global burden of AUD, which affects an estimated 280 million people and is associated with high morbidity and mortality [34]
Very few supplements focus on T3 levels and instead support T4 thyroid hormone which is inactive
Pushes Into Phase 3 With Strong Momentum Viking Therapeutics advanced its dual GLP-1/GIP agonist VK2735 into Phase 3 after achieving 14.7% weight loss without plateauing in Phase 2, positioning the program as a serious challenger in a rapidly expanding $150B obesity market